PhaRA is a team of over 50 Regulatory Affairs Professionals with a successful track record in submission and approval of regulatory applications and interactions with regulators. PhaRA is committed to meet regulatory milestones in drug development, bringing medicines to patients and keeping approved medicines on the market. By focusing exclusively on regulatory affairs, PhaRA can offer in-depth knowledge, insight, skills, and expertise covering a broad range of regulatory affairs activities and therapeutic areas.
We can support your innovative development of immunotherapeutics, vaccines, and other medical need areas because
- We have specific expertise in vaccines, immunology, oncology and infectious diseases.
- We support top 10 pharma and biotech clients with innovative vaccines and immunotherapeutics, including novel production platforms and addressing global public health needs.
- We have a thorough understanding and established relationship of >20 years with the Belgian Agency (FAMPH), EMA and EU Agencies with spearheads in these areas.
- Our diverse resourceful team includes Senior Advisors with an exAgency background (exPDCO/CHMP/SAWP/COMP) and former Sr VPs Global RA in large pharma.
